Smart-money news
What whales, hedge funds and billionaires are doing right now — from official filings
Congressman Dan Newhouse Rebalances Portfolio: Buys Infrastructure and Mobility, Sells Tech and Pharma
The House Representative executes a series of diverse transactions, including purchases in traditional and innovative sectors, alongside selling holdings in technology and biotech companies.
Congressman Dan Newhouse, a House Representative, executed a series of transactions in his investment portfolio on July 10, 2026, indicating a rebalancing of his market exposure. Newhouse purchased shares of Duke Energy Corp ($DUK), an electric and gas utility company, Uber Technologies Inc. ($UBER), a transportation technology company, Amcor PLC ($AMCR), a packaging company, Amphenol Corp ($APH), a connector manufacturer, and Arista Networks Inc. ($ANET), a network equipment company. Each purchase ranged from $1,001 to $15,000.
Concurrently with these purchases, Newhouse sold holdings in several technology, industrial, and pharmaceutical companies. Among the sold stocks were Applied Materials Inc. ($AMAT), FMC Corp ($FMC), Magna International Inc. ($MGA), Eli Lilly and Co ($LLY), Palo Alto Networks Inc. ($PANW), Advanced Micro Devices Inc. ($AMD), and Alphabet Inc. ($GOOGL). Here too, each sale ranged from $1,001 to $15,000.
Congressional transactions are reported in ranges and with a delay, but they provide a glimpse into the investment activity of individuals with access to broad information. Newhouse's moves reflect a strategy of diversification and adaptation to market conditions, with a certain shift from technology and pharma companies that experienced strong growth, towards infrastructure, services, and mobility companies. Individual traders can learn from this about the importance of adjusting one's portfolio to broader economic trends and the need for flexibility in sector selection.
Sources
Stories are auto-written from official filings (SEC, congressional disclosures, USAspending) and financial press, with AI assistance. Inaccuracies are possible; 13F filings lag by up to 45 days. For research only — not investment advice or a recommendation.
